'Lazarus' drug pulling men with lethal prostate cancer back from the brink through pioneering immunotherapy treatment
Scores of men with the most lethal form of prostate cancer have been ‘brought back from the brink of death’ by a drug found to work where all others have failed in a groundbreaking British-led trial.
Some patients whose bodies were riddled with cancer have had ‘Lazarus-like’ recoveries – and now show no visible signs of disease 18 months or more later, according to the doctor leading research into the treatment.
The medication, called pembrolizumab, is a type of immunotherapy that harnesses the body’s immune system to seek out and destroy tumour cells. It has already been shown to be highly effective in tackling other forms of the disease, including skin and lung cancer.
Scores of men with the most lethal form of prostate cancer have been ‘brought back from the brink of death’ by a drug found to work where all others have failed in a groundbreaking British-led trial
Now, a new study led by The Institute of Cancer Research and the Royal Marsden Hospital in London has found ‘amazing’ results in those with prostate cancer.
The disease is the most common form of male cancer: one in eight will be diagnosed with it during their lifetime. There are 47,000 new prostate cancer diagnoses annually in the UK alone, resulting in 11,000 deaths a year.
The trial looked at 258 men who had undergone numerous other treatments, including surgery, hormonal drugs and chemotherapy, to no avail. In many of them, the cancer had spread to their bones, usually a sign there is no more hope.
Read more: http://www.dailymail.co.uk/health/article-5798717/Men-untreatable-prostate-cancer-halt-spread-live-longer.html#ixzz5HXxTYMQw
Follow us: @MailOnline on Twitter | DailyMail on Facebook